Home/Filings/4/0001415889-25-017845
4//SEC Filing

Machado Patrick 4

Accession 0001415889-25-017845

CIK 0001501756other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:21 PM ET

Size

7.8 KB

Accession

0001415889-25-017845

Insider Transaction Report

Form 4
Period: 2025-06-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-17+10,45010,450 total
    Exercise: $2.32Exp: 2035-06-16Common Stock (10,450 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-06-17+3,1403,140 total
    Exercise: $2.32Exp: 2035-06-16Common Stock (3,140 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable on the earlier of June 17, 2026 or the 2026 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.

Issuer

Adverum Biotechnologies, Inc.

CIK 0001501756

Entity typeother

Related Parties

1
  • filerCIK 0001311210

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:21 PM ET
Size
7.8 KB